These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 38689006)
1. Longitudinal study investigating the influence of COMT gene polymorphism on cortical thickness changes in Parkinson's disease over four years. Tajerian A Sci Rep; 2024 Apr; 14(1):9920. PubMed ID: 38689006 [TBL] [Abstract][Full Text] [Related]
2. The catechol-O-methyltransferase Val(158)Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson's disease: a PET study. Wu K; O'Keeffe D; Politis M; O'Keeffe GC; Robbins TW; Bose SK; Brooks DJ; Piccini P; Barker RA Brain; 2012 Aug; 135(Pt 8):2449-57. PubMed ID: 22843413 [TBL] [Abstract][Full Text] [Related]
4. COMT gene and risk for Parkinson's disease: a systematic review and meta-analysis. Jiménez-Jiménez FJ; Alonso-Navarro H; García-Martín E; Agúndez JA Pharmacogenet Genomics; 2014 Jul; 24(7):331-9. PubMed ID: 24819480 [TBL] [Abstract][Full Text] [Related]
5. Patterns of cortical thickness and surface area in early Parkinson's disease. Jubault T; Gagnon JF; Karama S; Ptito A; Lafontaine AL; Evans AC; Monchi O Neuroimage; 2011 Mar; 55(2):462-7. PubMed ID: 21184830 [TBL] [Abstract][Full Text] [Related]
6. Progression of small vessel disease correlates with cortical thinning in Parkinson's disease. Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Tan L; Kandiah N Parkinsonism Relat Disord; 2016 Oct; 31():34-40. PubMed ID: 27397577 [TBL] [Abstract][Full Text] [Related]
7. Cortical Thinning and Cognitive Impairment in Parkinson's Disease without Dementia. Zhang L; Wang M; Sterling NW; Lee EY; Eslinger PJ; Wagner D; Du G; Lewis MM; Truong Y; Bowman FD; Huang X IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(2):570-580. PubMed ID: 29610105 [TBL] [Abstract][Full Text] [Related]
8. APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression. Paul KC; Rausch R; Creek MM; Sinsheimer JS; Bronstein JM; Bordelon Y; Ritz B J Parkinsons Dis; 2016 Apr; 6(2):349-59. PubMed ID: 27061069 [TBL] [Abstract][Full Text] [Related]
9. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications. Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Tan EK; Drozdzik M Pharmacogenet Genomics; 2008 Sep; 18(9):815-21. PubMed ID: 18698234 [TBL] [Abstract][Full Text] [Related]
17. Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysis. Uribe C; Segura B; Baggio HC; Abos A; Garcia-Diaz AI; Campabadal A; Marti MJ; Valldeoriola F; Compta Y; Tolosa E; Junque C Parkinsonism Relat Disord; 2018 May; 50():3-9. PubMed ID: 29449187 [TBL] [Abstract][Full Text] [Related]
18. MAO-B and COMT Genetic Variations Associated With Levodopa Treatment Response in Patients With Parkinson's Disease. Sampaio TF; Dos Santos EUD; de Lima GDC; Dos Anjos RSG; da Silva RC; Asano AGC; Asano NMJ; Crovella S; de Souza PRE J Clin Pharmacol; 2018 Jul; 58(7):920-926. PubMed ID: 29578580 [TBL] [Abstract][Full Text] [Related]
19. Cortical thinning is associated with disease stages and dementia in Parkinson's disease. Zarei M; Ibarretxe-Bilbao N; Compta Y; Hough M; Junque C; Bargallo N; Tolosa E; Martí MJ J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):875-81. PubMed ID: 23463873 [TBL] [Abstract][Full Text] [Related]
20. Cortical thickness and gyrification index measuring cognition in Parkinson's disease. Chaudhary S; Kumaran SS; Goyal V; Kaloiya GS; Kalaivani M; Jagannathan NR; Sagar R; Mehta N; Srivastava AK Int J Neurosci; 2021 Oct; 131(10):984-993. PubMed ID: 32423354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]